Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Mechanism of HCV resistance to interferon discovered

April 16, 1997

Milestone reached in Genome Therapeutics/Astra H. pylori collaboration

April 11, 1997

Encouraging phase III results reported for lamivudine as hepatitis B treatment

April 11, 1997

Taisho/Ikeda Mohando describe anti-H. pylori agent

April 9, 1997

Fujisawa reports antiulcer agents

April 9, 1997

5-LO inhibitor not effective as monotherapy in active ulcerative colitis

April 7, 1997

Positive phase III results reported for Centocor's Crohn's disease treatment

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Transdermal nicotine associated with clinical improvement in ulcerative colitis

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...